Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's disease pathology in subjective cognitive decline and mild cognitive impairment

The aim of this study is to investigate the role of plasma phosphorylated tau (p-tau) 181 as a potential biomarker for Alzheimer's Disease (AD) pathology in the early stages of the disease, as a valuable marker for tauopathy.

Source: Journal of the Neurological Sciences - September 11, 2023 Category: Neurology Authors: Giulia Giacomucci, Salvatore Mazzeo, Chiara Crucitti, Assunta Ingannato, Silvia Bagnoli, Sonia Padiglioni, Giulia Galdo, Filippo Emiliani, Daniele Frigerio, Valentina Moschini, Carmen Morinelli, Sandro Sorbi, Valentina Bessi, Benedetta Nacmias Source Type: research